Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

476 projects found matching your search criteria :

  1. Integrative analysis of tRNA modification circuits and aminoacylation and their role in breast cancer model.

    Call: OPUS 29 , Panel: NZ2

    Principal investigator: dr Marcin Sajek

    Instytut Genetyki Człowieka PAN

  2. FHOD1 as a Regulator of Lipid Droplet–Mitochondria Interactions: A New Dimension of Metabolic Control in Skin Melanoma C...

    Call: OPUS 29 , Panel: NZ3

    Principal investigator: dr hab. Antonina Joanna Mazur

    Uniwersytet Wrocławski

  3. The role of CXXC5 in the epigenetic profile of Hodgkin lymphoma

    Call: PRELUDIUM 24 , Panel: NZ2

    Principal investigator: Daniel Sikora

    Instytut Genetyki Człowieka PAN

  4. Role of the BRM- ERα interaction in the conferring of resistance to paclitaxel in BRG1-deficient cancers

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Karolina Gronkowska

    Uniwersytet Łódzki

  5. Genetic factors influencing response to immunotherapy and prognosis in patients with melanoma brain metastases

    Call: PRELUDIUM 24 , Panel: NZ2

    Principal investigator: Piotr Jan Błoński

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  6. Molecular pathways involved in nuclear membrane stress adaptation and its role in breast and prostate cancer

    Call: OPUS 29 , Panel: NZ3

    Principal investigator: dr Paulina Nastały

    Gdański Uniwersytet Medyczny

  7. M. bovis BCG extracellular vesicles as an alternative in bladder cancer immunotherapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Jakub Smoliński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  8. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  9. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Patryk Szymaszek

    Politechnika Krakowska im. Tadeusza Kościuszki

  10. Small non-coding RNAs as early indicators of carcinogenesis in inherited DNA repair disorders

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Katarzyna Izabela Płoszka

    Uniwersytet Medyczny w Łodzi

  11. Development of the fluorescence multifunctional biosensing system based on antisense oligonucleotide probes for the onco...

    Call: PRELUDIUM 24 , Panel: ST4

    Principal investigator: Hubert Grzegorz Grel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  12. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  13. Synergistic enhancement of reactive oxygen species generation via combination of heavy atom effect with donor-acceptor a...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Karolina Anna Urbanowicz

    Politechnika Warszawska

  14. Metabolic biomarkers of prostate cancer

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Tomasz Łukasz Ruman

    Politechnika Rzeszowska im. Ignacego Łukasiewicza

  15. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

  17. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Natalia Anna Lehman

    Uniwersytet Medyczny w Lublinie

  18. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK ...

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

  19. "The Role of Adipose Tissue and microRNA in the Progression of Clear Cell RenalCell Carcinoma".

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Dorota Małgorzata Kwapisz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  20. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

  21. Rola TRIM32 i TRIM34 w regulacji metabolizmu guza i mikrośrodowiska immunologicznego w raku jajnika

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Alicja Katarzyna Rajtak

    Uniwersytet Medyczny w Lublinie

  22. We are Left Without Oxygen—Now What?: Evaluation of Hypoxia-Inducible COL Family Genes in Glioblastoma Patients and Thei...

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: prof. Ewa Izabela Balcerczak

    Uniwersytet Medyczny w Łodzi

  23. The role of IFN-γ in inducing phenotype alterations and disulfidptosis in drug-naïve and BRAFV600/MEK inhibitor-resistan...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Piotr Wawrzyniak

    Uniwersytet Medyczny w Łodzi

  24. Intestinal barrier dysfunction as a risk factor for pancreatic ductal adenocarcinoma: impact of fatty acid intake, with ...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Wojciech Michał Jankowski

    Uniwersytet Medyczny w Łodzi

  25. Influence of ER stress on the hormonal activity of pituitary neuroendocrine tumors (PitNETs)

    Call: SONATINA 9 , Panel: NZ4

    Principal investigator: dr Beata Krystyna Rak-Makowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  26. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d...

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Krzysztof Bartnik

    Politechnika Warszawska

  27. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  28. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

  29. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  30. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

  31. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  32. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  33. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  34. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  35. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  36. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  37. Biomaterial enriched with propolis extract as a promising chemopreventive dressing material after melanoma excision

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Marta Trzaskowska

    Uniwersytet Medyczny w Lublinie

  38. Cellular effects in the tumor microenvironment and the potential for targeted delivery of molecules associated with the ...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Magdalena Maria Staniszewska

    Katolicki Uniwersytet Lubelski Jana Pawła II

  39. N6-methyladenine metabolism - potential relationships with the development of hematological malignancies.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Marta Starczak

    Uniwersytet Mikołaja Kopernika

  40. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Dorota Helbik-Maciejewska

    Uniwersytet Gdański

  41. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  42. Identification of novel microRNA biomarkers in liquid biopsy of patients with neuroendocrine tumors

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Paweł Mateusz Komarnicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  43. (Lipid-FLUX) Single-cell lipidomics by spectroscopy: Quantification of the lipid transport through the development of ne...

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Małgorzata Anna Barańska

    Uniwersytet Jagielloński

  44. Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  45. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  46. Neutrophil-targeted immune response as an effective approach in immunotherapyof gastrointestinal cancers

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Damian Jacenik

    Uniwersytet Łódzki

  47. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  48. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  49. EGR1 Protein: A Key Factor in Cellular Homeostasis?

    Call: PRELUDIUM 23 , Panel: NZ3

    Principal investigator: Marta Leśniczak-Staszak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  50. The two are better than one - biferrocenyl ROS generators as intelligent anticancer agents

    Call: OPUS 27 , Panel: ST5

    Principal investigator: prof. Konrad Maciej Kowalski

    Uniwersytet Łódzki